Association Between Mean Platelet Volume and Benign Prostatic Hyperplasia: A Population Study from the TCLSIH Cohort Study
Yanqi Song,Yeqing Gu,Honglei Guo,Honghao Yang,Xuena Wang,Hongmei Wu,Aidi Wang,Mengxiao Wang,Haijin Wang,Qing Zhang,Li Liu,Ge Meng,Baoshan Liu,Kaijun Niu
DOI: https://doi.org/10.2147/jir.s416404
IF: 4.5
2023-08-05
Journal of Inflammation Research
Abstract:Yanqi Song, 1 Yeqing Gu, 2 Honglei Guo, 3 Honghao Yang, 4– 6 Xuena Wang, 4– 6 Hongmei Wu, 4– 6 Aidi Wang, 1 Mengxiao Wang, 7 Haijin Wang, 1 Qing Zhang, 8 Li Liu, 8 Ge Meng, 6, 8– 10 Baoshan Liu, 1 Kaijun Niu 4– 6 1 Department of Traditional Chinese Medicine, Tianjin Medical University General Hospital, Tianjin, People's Republic of China; 2 Institute of Radiation Medicine, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, People's Republic of China; 3 Tianjin University of Traditional Chinese Medicine, Tianjin, People's Republic of China; 4 School of Public Health of Tianjin University of Traditional Chinese Medicine, Tianjin, People's Republic of China; 5 School of Integrative Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin, People's Republic of China; 6 Nutritional Epidemiology Institute and School of Public Health, Tianjin Medical University, Tianjin, People's Republic of China; 7 Binzhou Hospital of Chinese Medicine, Shandong, People's Republic of China; 8 Health Management Centre, Tianjin Medical University General Hospital, Tianjin, People's Republic of China; 9 Tianjin Key Laboratory of Environment, Nutrition and Public Health, Tianjin, People's Republic of China; 10 Department of Toxicology and Sanitary Chemistry, School of Public Health, Tianjin Medical University, Tianjin, People's Republic of China Correspondence: Kaijun Niu; Baoshan Liu, Nutritional Epidemiology Institute and School of Public Health, Tianjin Medical University, 22 Qixiangtai Road, Heping District, Tianjin, 300070, People's Republic of China, Tel +86-22-83336613, Email ; ; Purpose: This study aimed to prospectively investigate the association between mean platelet volume (MPV) levels and risk of benign prostatic hyperplasia (BPH) in a general Chinese adult male population, and assessed this association in metabolic syndrome (MetS) patients. Patients and methods: This study included a total of 14,923 male participants free from BPH at baseline. MPV was measured by the method of laser-based flow cytometric impedance according to the complete blood sample. BPH was defined as total prostate volume (TPV) ≥ 30 mL, TPV was determined by transabdominal ultrasonography. Multivariable Cox proportional hazards models were fitted to calculate hazards ratios (HRs) and corresponding 95% confidence intervals (CIs) for BPH risk with NLR levels. Results: During a median follow-up of 2.7 years, 4848 BPH cases were documented in total male participants, and 1787 BPH cases were documented in MetS participants. After adjusting for age, body mass index, smoking, alcohol and personal and family history of disease, the multivariable-adjusted HRs of BPH were 1.00 (reference), 1.03 (95% CIs 0.96, 1.11), 1.00 (95% CIs 0.92, 1.08) and 0.98 (95% CIs 0.90, 1.06), respectively, for participants with MPV in the 1st, 2nd, 3rd and 4th quartiles ( P for trend = 0.47). In MetS patients, the multivariable-adjusted HRs of BPH were 1.00 (reference), 1.03 (95% CIs 0.90, 1.16), 0.99 (95% CIs 0.87, 1.14) and 1.01 (95% CIs 0.89, 1.15) ( P for trend= 0.98), respectively. Conclusion: A non-significant association was observed between MPV levels and risk of BPH, and no association in this association in MetS patients. Our findings support the notion that MPV levels may not be a target for BPH prevention and intervention. Keywords: mean platelet volume, inflammation, benign prostatic hyerplasia, metabolic syndrome, prospective cohort study Prostate cancer (PC) is the fourth most frequent type of cancer in humans (7.3% of cases) and the second most lethal type of cancer in males. 1 Benign prostatic hyperplasia (BPH) is a histological condition that causes in benign prostate gland enlargement and is a risk factor for developing PC. 2,3 In BPH, the transition zone (TZ) and periurethral area exhibit uncontrollable proliferation of epithelial and fibromuscular tissue. 4 Poor urine flow, frequent urination, difficulty starting the flow, post-void dribbling, and nocturia are some symptoms that may occur in men with BPH. 4 Metabolic syndrome (MetS), a risk factor for cardiovascular disease (CVD), refers to a group of disorders including abdominal obesity, diabetes mellitus, hypertension, low high-density lipoprotein cholesterol (HDL-C), and hypertriglyceridemia, with insulin resistance as a potentially defining characteristic. 5 MetS also play a significant role in the development and progression of BPH, according to recent studies.<su -Abstract Truncated-
immunology